Defining episodes of diarrhoea: results from a three-country study in Sub-Saharan Africa

James A Wright1, Stephen W Gundry, Ronan Conroy

  • 1Department of Geography, University of Southampton, Highfield, Southampton SO17 1BJ, UK. J.A.Wright@soton.ac.uk

Insights

Defining diarrhoeal episodes significantly impacts morbidity estimates. This study developed adjustment factors to standardize diarrhoeal morbidity data, ensuring more accurate comparisons across studies.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatrics

Background:

  • Diarrhoeal diseases are a major cause of child morbidity globally.
  • Inconsistent definitions of diarrhoeal episodes complicate accurate morbidity assessment.
  • Standardization is crucial for reliable epidemiological data and systematic reviews.

Purpose of the Study:

  • To evaluate the impact of different episode definitions on diarrhoeal morbidity estimates.
  • To develop adjustment factors for standardizing diarrhoeal morbidity data.
  • To promote consistent methodologies in diarrhoeal disease research.

Main Methods:

  • A cohort study involving 374 children aged 9-32 months in three African countries.
  • Recording stool frequency and consistency over a seven-month period.
  • Applying various episode definitions to assess effects on annualized diarrhoeal morbidity.

Main Results:

  • Non-standard episode definitions altered annualized episode estimates by 38% to 137% compared to the international standard.
  • Derived adjustment factors can correct morbidity estimates for non-standard definitions.
  • Significant variability in morbidity estimates based on definition used.

Conclusions:

  • The definition of a diarrhoeal episode critically influences morbidity estimates.
  • Standard definitions and field protocols are recommended for diarrhoeal disease research.
  • Adjustment factors are essential for pooling and comparing diarrhoeal morbidity data, especially in systematic reviews.

Related Concept Videos

Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...